Boceprevir-d9

Cat. No.: IBDI-434405

Boceprevir-d9 is the deuterium labeled Boceprevir. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay. Boceprevir inhibits SARS-CoV-2 3CLpro activity.

Product Details

Target	HCV | Protease | HCV | SARS-CoV
Molecular Weight	528.73
Synonyms	EBP 520-d9, SCH 503034-d9
SMILES	NC(C(C(CC1CCC1)NC([[email protected]@H]2[[email protected]]3([H])[[email protected]@](CN2C([[email protected]](C(C)(C)C)NC(NC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)=O)([H])C3(C)C)=O)=O)=O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.